CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 18, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

June 30, 2022

Conditions
Prostate Cancer
Interventions
BEHAVIORAL

Experimental: Arm 1 (Aerobic Exercise)

This periodized program consists of 3 aerobic exercise sessions per week comprised of two high-intensity interval training workouts and 1 continuous vigorous intensity workout.

BEHAVIORAL

Experimental: Arm 2 (Resist. Exercise)

This periodized program consisting of 3 resistance exercise sessions per week comprised of high load/low volume, light load/high volume, and moderate load/moderate volume.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT02613273 - CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter